Renowned evolutionary biologist Daniel E. Lieberman, a professor at Harvard University, is turning heads — and slowing down treadmills — with his thought-provoking book Exercised. The core message?
As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American Medical Association, or JAMA ...